| Literature DB >> 3822251 |
J Hardy, R Cowburn, A Barton, G Reynolds, P Dodd, P Wester, A M O'Carroll, E Lofdahl, B Winblad.
Abstract
Synaptosomal gamma-aminobutyric acid (GABA) uptake has been used as a biochemical marker for GABAergic terminals in controls and Alzheimer disease brains. Use of this marker suggests a large (ca. 70%) loss of cortical and hippocampal GABA terminals in Alzheimer brain. To explain this observation we suggest that neuron loss in this disorder occurs via a process of cortical retrograde degeneration. This scheme reconciles our findings with previous neurochemical measurements on Alzheimer disease brains and also better reconciles the biochemistry with the histology of the disorder.Entities:
Mesh:
Substances:
Year: 1987 PMID: 3822251 DOI: 10.1016/0304-3940(87)90016-4
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046